Carta Healthcare Secures $18.25 Million for AI-Powered Clinical Data Solutions

Carta Healthcare has raised $18.25 million in Series B1 funding to enhance its AI-driven clinical data abstraction and analytics services, announced in a press release.

Carta Healthcare has secured $18.25 million in Series B1 funding to advance its AI-powered clinical data abstraction and analytics services, announced in a press release. The investment round was led by UPMC Enterprises, with participation from several strategic investors, including MemorialCare Innovation Fund and Rex Health Ventures.

The funding will enable Carta Healthcare to expand its customer base, particularly in the life sciences sector, and enhance its AI-driven solutions that streamline clinical data abstraction. This comes after the company's acquisition of Realyze Intelligence, which uses AI to analyze structured and unstructured data for clinical trials and research studies.

Brent Burns, Executive Vice President at UPMC Enterprises, highlighted the importance of Carta Healthcare's technology in addressing the challenges of clinical data abstraction and patient trial matching. The investment aims to support the company's mission to provide actionable insights that improve patient care and operational efficiency in healthcare systems.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Healthcare & Life Sciences AI

AI Brief (X)

More from: Funding

Clio to Acquire vLex for $1 Billion, Expanding AI Legal Technology

Jun 30

Recognize Closes $1.7 Billion Fund for Digital Services Investments

Jun 30

Chang Robotics Fund Deploys Initial Capital to Boost U.S. Manufacturing

Jun 30

Audos Secures $11.5 Million to Empower AI Entrepreneurs

Jun 30

Gensmo Secures $60M to Revolutionize Fashion E-Commerce with AI

Jun 30

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.